thymidine has been researched along with methyl-thiohydantoin-tryptophan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Ando, N; Furuichi, Y; Goi, K; Inukai, T; Kagami, K; Kasai, S; Nagano, O; Nakane, T; Ohno, S; Okazaki, S; Saitoh, S; Saya, H; Sugita, K | 1 |
1 other study(ies) available for thymidine and methyl-thiohydantoin-tryptophan
| Article | Year |
|---|---|
Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.
Topics: Biological Transport; Cell Line, Tumor; Cell Survival; Child; Child, Preschool; Female; Gene Expression; HMGB1 Protein; Humans; Hyaluronan Receptors; Hyaluronic Acid; Imidazoles; Indoles; Infant; Male; Molecular Weight; Necrosis; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cells, B-Lymphoid; Reactive Oxygen Species; Thymidine | 2017 |